LYFT vs STRO
LYFT Inc (LYFT) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported LYFT revenue for 2024-12-31 was $5.79B. Net income was $22.8M. Revenue was up 31.4% from 2023-12-31 to 2024-12-31. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
LYFT currently screens at market cap $6.79B and trailing P/E 107.7. STRO currently screens at market cap $470.8M.
Not investment advice. Open the LYFT and STRO stock pages for the full models.
Not investment advice.